Spearhead Capital Advisors, LLC Fulgent Genetics, Inc. Transaction History

Spearhead Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$47.98 - $62.75 $23,174 - $30,308	483 Added 12.7%	4,287 $234,000
Q1 2022 Apr 28, 2022	SELL	$49.85 - $96.11 $103,289 - $199,139	-2,072 Reduced 35.26%	3,804 $237,000
Q4 2021 Jan 25, 2022	BUY	$77.3 - $105.0 $4,715 - $6,405	61 Added 1.05%	5,876 $591,000
Q3 2021 Oct 27, 2021	SELL	$74.87 - $110.87 $1,347 - $1,995	-18 Reduced 0.31%	5,815 $523,000
Q2 2021 Aug 10, 2021	BUY	$66.8 - $100.45 $41,549 - $62,479	622 Added 11.94%	5,833 $538,000
Q1 2021 Apr 28, 2021	BUY	$59.3 - $183.85 $309,012 - $958,042	5,211 New	5,211 $503,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.